This issue of Mayo Magazine focuses on innovation and how at Mayo Clinic, innovative thinking leads to improved patient care. From developing new techniques to treat deficiencies of the digestive tract, to using simulation education to enhance skills and practice hands-on emergency interventions and techniques, to designing a less-invasive way to repair the heart's mitral valve, Mayo Clinic is leading the way in the kind of innovation that benefits our patients.
This issue also features many of our generous benefactors, whose philanthropic gifts have aided in Mayo's ability to be a leader in translating genomics-based discoveries into enhanced ways of understanding, diagnosing, treating and preventing disease. With your help, we can continue to remain loyal to our primary commitment — to provide the best care to every patient every day.
For 10 weeks every summer, Summer Undergraduate Research Fellowship (SURF) students, college students from around the country, come to Mayo to explore their burgeoning interest in science.
or 10 weeks every summer, Summer Undergraduate Research Fellowship (SURF) students, college students from around the country, come to Mayo to explore their burgeoning interest in science.
Few diagnoses are more dreaded than amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, but the ALS Clinic in Jacksonville challenges the outdated, but still prevealent, opinion that "nothing can be done."
Located on the campus of Mayo Clinic Rochester, the simulation center offers health care teams with the opportunity to practice hands-on emergency, surgical and intensive-care interventions and techniques on Stan, the standard patient simulator. More than a mannequin, Stan is programmed to give human-like responses to medications and treatments.
The beat goes on as physician-inventors discover a new way to operate on the mitral valve while the heart is still beating.
Researchers ramp up to conduct clinical trials on an existing arthritis medication, which may also prove to be a new therapy for non-small cell lung cancer (NSCLC), the leading cause of cancer-related death in the United States.
Denis A. Cortese, M.D., president and chief executive officer of Mayo Clinic talks about Mayo's roles as a learning organization, a leader in health care reform and most importantly, Mayo's continued mission of providing the best care to every patient every day.
This issue of Mayo Magazine focuses on practice, education and research. Mayo's making strides in biomechanics, building our endowment, unraveling the link between sleep disorders and heart disease, halting Alzheimer's disease, jump starting health care reform, improving the drug development process and bridging yesterday's knowledge with today's medicine.
This issue also features many of our generous benefactors whose philanthropic gifts aid in Mayo Clinic's primary commitment — to provide the best care to every patient every day.
In the Motion Analysis Laboratories at Mayo Clinic, the principles of mathematics, engineering and physics are applied to human movement, a science called biomechanics. This is where diverse teams of Mayo Clinic experts use the tools of biomechanics to solve everyday issues.
Many funds, most of which come from benefactor-designated gifts, make up the Mayo Clinic endowment, a pool of money that's invested for the future. Each year a portion of the income that comes from the endowment is distributed to physicians, scientists and students to support innovative research and education activities, all with the goal of advancing patient care.
Mayo Clinic College of Medicine, like many other academic health centers, honors outstanding faculty through named professorships.
Virend Somers, M.D., Ph.D., a Mayo Clinic cardiologist and sleep medicine physician and director of the Sleep Disorders Research Lab at Mayo Clinic Rochester, identifies and researches connections among sleep disorders, heart disease and sudden death.
In July 2005, a research team including Mayo Clinic investigators made an astonishing discovery: It may be possible to reverse much of the memory loss that occurs with Alzheimer's disease and similar disorders, even in people who are in the later stages of the disease.
When Michael O'Connor, Ph.D., realized that standard mammography devices weren't real effective for women with dense breast tissue, he compiled a "new" imaging system.
There is a potential treatment for congestive heart failure involving the green mamba snake. This story describes a novel compound that shows promise as a treatment for patients with congestive heart failure and the critical importance of collaboration and teamwork.
W. Bruce Fye, M.D., M.A., a Mayo Clinic consultant in cardiology and a recognized leader in his medical specialty and in the history of medicine, discusses the importance of history at Mayo Clinic.
Abbigail and Isabelle Carlsen, conjoined twin daughters of Amy and Jesse Carlsen of Fargo, N.D., were separated at Mayo Eugenio Litta Children's Hospital on Friday, May 12.
This issue of Mayo Magazine focuses on the science of genomics, the study of an individual's genetic makeup. In this edition, we give our readers an overview of genomics and a look at what this science means in the areas of childhood leukemia, Parkinson's disease, kidney cancer, alcoholism and a heart-related disorder that may be the culprit in the sudden, unexplained deaths of young people. We will take you inside the genomics revolution and highlight Mayo's research in this important area of study.
This issue also features many of our generous benefactors whose philanthropic gifts have aided in Mayo's ability to be a leader in translating genomics-based discoveries into enhanced ways of understanding, diagnosing, treating and preventing disease. With your help, we can continue to remain loyal to our primary commitment — to provide the best care to every patient every day.
The understanding of genomics — the study of the genetic makeup of an organism — and the understanding of proteomics — the study of how proteins help direct cell behavior — will have a tremendous impact on the understanding of human health.
Genomic researchers at Mayo Clinic have 98 years of patient samples and data from which to draw.
Focused research on understanding the genetic underpinnings for sudden, unexplained deaths in infants, children, adolescents and young adults.
"Within five years, we could predict with a great deal of accuracy who will get Parkinson's disease and also what therapeutic developments can significantly slow or halt the disease," says Demetrius M. Maraganore, M.D.
Renal cell carcinoma (RCC) is the most common form of kidney cancer in the United States. Learn how Mayo Clinic researchers are identifying genes that influence the spread of RCC.
The name SC Johnson is known around the world for a range of household products. At Mayo Clinic, the Johnson name is associated with help in establishing the Mayo Clinic Samuel C. Johnson Genomics of Addiction Program.
For those touched by inherited diseases, genetics is not a dry, academic subject but rather a very personal, often heart-wrenching narrative. It is a story for which they seek a better outcome.
As a science, pharmacogenomics is the study of how a person responds to (or metabolizes) a drug.